Long Terms Follow-Up of the Randomized MetaspHER Study Comparing Intravenous Versus Subcutaneous Trastuzumab in Patients’ With HER2-Positive Metastatic Breast Cancer
Titel:
Long Terms Follow-Up of the Randomized MetaspHER Study Comparing Intravenous Versus Subcutaneous Trastuzumab in Patients’ With HER2-Positive Metastatic Breast Cancer
Auteur:
Pivot, Xavier Spano, Jean-Philippe Espie, Marc Jouannaud, Christelle Pottier, Valerie Moreau, Laura Extra, Jean Marc Lortholary, Alain Rivera, Pascale Spaeth, dominique Mouri, Zahira Tariket, Fella Dupin, Julien Berthois, Aurelien Ionescu-Goga, Miruna Ferhat, Abdennour Cottu, Paul Gligorov, Joseph